{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:08:09Z","timestamp":1784304489622,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanghai Science and Technology Commission Science and technology innovation action plan","award":["23Y11921500"],"award-info":[{"award-number":["23Y11921500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04614-w","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T06:11:43Z","timestamp":1759385503000},"page":"3575-3587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u03b2-sitosterol attenuates hepatic lipid accumulation and fibrosis via NLRP3 signaling in MASH mice"],"prefix":"10.1007","volume":"399","author":[{"given":"Xuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"1","key":"4614_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40360-023-00671-0","volume":"24","author":"OA Abo-Zaid","year":"2023","unstructured":"Abo-Zaid OA, Moawed FS, Ismail ES, Farrag MA (2023) Beta-sitosterol attenuates high- fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway. BMC Pharmacol Toxicol 24(1):31","journal-title":"BMC Pharmacol Toxicol"},{"key":"4614_CR2","doi-asserted-by":"publisher","first-page":"110702","DOI":"10.1016\/j.biopha.2020.110702","volume":"131","author":"S Babu","year":"2020","unstructured":"Babu S, Jayaraman S (2020) An update on beta-sitosterol: a potential herbal nutraceutical for diabetic management. Biomed Pharmacother 131:110702","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4614_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.nutres.2008.02.003","volume":"28","author":"G Brufau","year":"2008","unstructured":"Brufau G, Canela MA, Rafecas M (2008) Phytosterols: physiologic and metabolic aspects related to cholesterol-lowering properties. Nutr Res 28(4):217\u2013225","journal-title":"Nutr Res"},{"issue":"3","key":"4614_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1021\/jf404955n","volume":"62","author":"J Chen","year":"2014","unstructured":"Chen J, Jiao R, Jiang Y, Bi Y, Chen Z (2014) Algal sterols are as effective as beta-sitosterol in reducing plasma cholesterol concentration. J Agric Food Chem 62(3):675\u2013681","journal-title":"J Agric Food Chem"},{"issue":"11","key":"4614_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41423-018-0032-0","volume":"16","author":"X Du","year":"2019","unstructured":"Du X, Wu Z, Xu Y, Liu Y, Liu W, Wang T et al (2019) Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. Cell Mol Immunol 16(11):878\u2013886","journal-title":"Cell Mol Immunol"},{"key":"4614_CR6","doi-asserted-by":"publisher","first-page":"118966","DOI":"10.1016\/j.lfs.2020.118966","volume":"270","author":"X Fang","year":"2021","unstructured":"Fang X, Du Z, Duan C, Zhan S, Wang T, Zhu M et al (2021) Beinaglutide shows significantly beneficial effects in diabetes\/obesity-induced nonalcoholic steatohepatitis in ob\/ob mouse model. Life Sci 270:118966","journal-title":"Life Sci"},{"key":"4614_CR7","doi-asserted-by":"crossref","unstructured":"Feng S, Dai Z, Liu AB, Huang J, Narsipur N, Guo G et al (2018) Intake of stigmasterol and beta-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. Biochim Biophys Acta Mol Cell Biol Lipids 1863(10): 1274\u20131284","DOI":"10.1016\/j.bbalip.2018.08.004"},{"key":"4614_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H (2023) Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol 41:301\u2013316","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"4614_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA et al (2021) Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol 74(1):156\u2013167","journal-title":"J Hepatol"},{"issue":"1","key":"4614_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1139\/cjpp-2019-0295","volume":"98","author":"NM Gumede","year":"2020","unstructured":"Gumede NM, Lembede BW, Nkomozepi P, Brooksbank RL, Erlwanger KH, Chivandi E (2020) Beta-sitosterol mitigates the development of high-fructose diet-induced nonalcoholic fatty liver disease in growing male Sprague-Dawley rats. Can J Physiol Pharmacol 98(1):44\u201350","journal-title":"Can J Physiol Pharmacol"},{"key":"4614_CR11","doi-asserted-by":"crossref","unstructured":"Hah Y, Lee WK, Lee S, Kim EJ, Lee JH, Lee S et al (2022) beta-Sitosterol attenuates dexamethasone-induced muscle atrophy via regulating FoxO1-dependent signaling in C2C12 cell and mice model. Nutrients 14(14)","DOI":"10.3390\/nu14142894"},{"issue":"10","key":"4614_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F (2023) Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol 20(10):633\u2013646","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"4614_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison SA, Allen AM, Dubourg J, Noureddin M, Alkhouri N (2023) Challenges and opportunities in NASH drug development. Nat Med 29(3):562\u2013573","journal-title":"Nat Med"},{"issue":"7","key":"4614_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL (2022) Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol 22(7):429\u2013443","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4614_CR15","doi-asserted-by":"publisher","first-page":"100330","DOI":"10.1016\/j.jlr.2023.100330","volume":"64","author":"GN Ioannou","year":"2023","unstructured":"Ioannou GN, Horn CL, Kothari V, Yeh MM, Shyu I, Lee SP et al (2023) Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH. J Lipid Res 64(2):100330","journal-title":"J Lipid Res"},{"issue":"10","key":"4614_CR16","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1136\/gutjnl-2020-322509","volume":"70","author":"EH Koh","year":"2021","unstructured":"Koh EH, Yoon JE, Ko MS, Leem J, Yun J, Hong CH et al (2021) Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis. Gut 70(10):1954\u20131964","journal-title":"Gut"},{"key":"4614_CR17","doi-asserted-by":"publisher","first-page":"156030","DOI":"10.1016\/j.phymed.2024.156030","volume":"135","author":"J Li","year":"2024","unstructured":"Li J, Meng Z, Wen H, Lu C, Qin Y, Xie Y et al (2024) Beta-sitosterol alleviates pulmonary arterial hypertension by altering smooth muscle cell phenotype and DNA damage\/cGAS\/STING signaling. Phytomedicine 135:156030","journal-title":"Phytomedicine"},{"issue":"10","key":"4614_CR18","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1039\/D3FO00772C","volume":"14","author":"L Ma","year":"2023","unstructured":"Ma L, Ma Y, Liu Y (2023) Beta-Sitosterol protects against food allergic response in BALB\/c mice by regulating the intestinal barrier function and reconstructing the gut microbiota structure. Food Funct 14(10):4456\u20134469","journal-title":"Food Funct"},{"issue":"8","key":"4614_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E (2018) Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 17(8):588\u2013606","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"4614_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM et al (2017) Nlrp3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66(5):1037\u20131046","journal-title":"J Hepatol"},{"issue":"5","key":"4614_CR21","doi-asserted-by":"publisher","first-page":"100281","DOI":"10.1016\/j.xcrm.2021.100281","volume":"2","author":"N Panayotis","year":"2021","unstructured":"Panayotis N, Freund PA, Marvaldi L, Shalit T, Brandis A, Mehlman T et al (2021) Beta-sitosterol reduces anxiety and synergizes with established anxiolytic drugs in mice. Cell Rep Med 2(5):100281","journal-title":"Cell Rep Med"},{"issue":"22","key":"4614_CR22","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313(22):2263\u20132273","journal-title":"JAMA"},{"issue":"5","key":"4614_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.9734\/EJMP\/2014\/7764","volume":"4","author":"S Saeidnia","year":"2014","unstructured":"Saeidnia S (2014) The story of beta-sitosterol- a review. Eur J Med Plants 4(5):590\u2013609","journal-title":"Eur J Med Plants"},{"issue":"7","key":"4614_CR24","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Tabas I, Pajvani UB (2020) Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158(7):1913\u20131928","journal-title":"Gastroenterology"},{"key":"4614_CR25","doi-asserted-by":"publisher","first-page":"609060","DOI":"10.3389\/fimmu.2020.609060","volume":"11","author":"Y Shi","year":"2020","unstructured":"Shi Y, Su W, Zhang L, Shi C, Zhou J, Wang P et al (2020) TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation. Front Immunol 11:609060","journal-title":"Front Immunol"},{"issue":"4","key":"4614_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.04.038","volume":"73","author":"Q Song","year":"2020","unstructured":"Song Q, Chen Y, Wang J, Hao L, Huang C, Griffiths A et al (2020) ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. J Hepatol 73(4):783\u2013793","journal-title":"J Hepatol"},{"issue":"4","key":"4614_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41423-019-0296-z","volume":"18","author":"X Unamuno","year":"2021","unstructured":"Unamuno X, Gomez-Ambrosi J, Ramirez B, Rodriguez A, Becerril S, Valenti V et al (2021) Nlrp3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling. Cell Mol Immunol 18(4):1045\u20131057","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"4614_CR28","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei W, Wong CC, Jia Z, Liu W, Liu C, Ji F et al (2023) Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid. Nat Microbiol 8(8):1534\u20131548","journal-title":"Nat Microbiol"},{"issue":"1","key":"4614_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu X, Poulsen KL, Wu L, Liu S, Miyata T, Song Q et al (2022) Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct Target Ther 7(1):287","journal-title":"Signal Transduct Target Ther"},{"key":"4614_CR30","doi-asserted-by":"publisher","first-page":"116952","DOI":"10.1016\/j.biopha.2024.116952","volume":"177","author":"Q Yong","year":"2024","unstructured":"Yong Q, Huang C, Chen B, An J, Zheng Y, Zhao L et al (2024) Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways. Biomed Pharmacother 177:116952","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4614_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15(1):11\u201320","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10215","key":"4614_CR32","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z et al (2019) Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 394(10215):2184\u20132196","journal-title":"Lancet"},{"issue":"5","key":"4614_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41374-021-00535-3","volume":"101","author":"LY Zhu","year":"2021","unstructured":"Zhu LY, Liu C, Li ZR, Niu C, Wu J (2021) NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water. Lab Invest 101(5):588\u2013599","journal-title":"Lab Invest"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04614-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04614-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04614-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:58:37Z","timestamp":1772006317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04614-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4614"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04614-w","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments and treatments on mice were in accordance with the International Guidelines for the Use of Laboratory Animals. The experimental animal protocols received the acceptance of the Ethics Committee of Shanghai University of Traditional Chinese Medicine (PZSHUTCM2301150008).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}